Antonin de Fougerolles

Antonin de Fougerolles is an accomplished biopharmaceutical executive with extensive experience in leading research and development efforts within the industry. Currently serving as Board Chair and member at etherna and LIfT BioSciences, Antonin is also a Board Member at Chimeron Bio and Walking Fish Therapeutics, Inc. Previously, Antonin held significant positions including CEO of Evox Therapeutics Ltd, Chief Scientific Officer at Ablynx, Tolerx Inc., and founding Chief Scientific Officer at Moderna Therapeutics, where crucial advancements in mRNA technology were made. Notably, Antonin played a vital role in the development of RNAi therapeutics at Alnylam Pharmaceuticals and conducted research at Biogen. Antonin's academic background includes a PhD in Immunology from Harvard University and a Bachelor of Science in Microbiology & Immunology from McGill University.